Top Pharmaceuticals companies in Poland by Receivables
Poland
# |
Name |
Receivables |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 406.13 M
|
Dec. 31, 2023 | USD 208.13 | 0.81% |
|
Poland |
|
| 2 |
USD 17.54 M
|
Dec. 31, 2023 | USD 10.78 | -0.36% |
|
Poland |
|
| 3 |
USD 9.25 M
|
Dec. 31, 2023 | USD 0.90 | -1.27% |
|
Poland |
|
| 4 |
USD 8.31 M
|
Dec. 31, 2023 | USD 5.95 | -0.32% |
|
Poland |
|
| 5 |
USD 6.47 M
|
Dec. 31, 2023 | USD 2.29 | -0.01% |
|
Poland |
|
| 6 |
USD 2.33 M
|
Dec. 31, 2023 | USD 6.78 | -1.52% |
|
Poland |
|
| 7 |
USD 1.80 M
|
Dec. 31, 2023 | USD 3.74 | 1.10% |
|
Poland |
|
| 8 |
USD 1.62 M
|
Dec. 31, 2023 | USD 12.77 | 1.67% |
|
Poland |
|
| 9 |
USD 1.42 M
|
Dec. 31, 2023 | USD 9.53 | -0.94% |
|
Poland |
|
| 10 |
USD 276.16 K
|
Dec. 31, 2023 | USD 0.27 | 2.93% |
|
Poland |
|
| 11 |
USD 32.21 K
|
Dec. 31, 2023 | USD 1.15 | -0.76% |
|
Poland |
|
| 12 |
USD 117.92
|
Dec. 31, 2023 | USD 21.83 | 2.30% |
|
Poland |
|
| 13 |
USD 0.00
|
Dec. 31, 2023 | USD 1.88 | 0.22% |
|
Poland |
|
| 14 |
USD 0.00
|
Dec. 31, 2023 | USD 1.23 | 1.32% |
|
Poland |
Frequently Asked Questions
-
Which Pharmaceuticals company in Poland has the highest Receivables ?
The Pharmaceuticals company in Poland with the highest Receivables is NEUCA S.A. (Warsaw Stock Exchange: NEU.WA) at USD 406.13 M.
-
Which Pharmaceuticals company in Poland has the lowest Receivables ?
The Pharmaceuticals company in Poland with the lowest Receivables is Synthaverse S.A. (Warsaw Stock Exchange: SVE.WA) at USD 0.00.
-
What are the top 10 Pharmaceuticals companies in Poland by Receivables ?
The top 10 Pharmaceuticals companies in Poland by Receivables are NEUCA S.A., Selvita S.A., BIOTON S.A., Celon Pharma S.A., Mabion S.A., Ryvu Therapeutics S.A., BioMaxima S.A., Captor Therapeutics Spolka Akcyjna, Poltreg S.A. and onesano S.A..
-
What are the bottom 10 Pharmaceuticals companies in Poland by Receivables ?
The bottom 10 Pharmaceuticals companies in Poland by Receivables are Synthaverse S.A., Medinice S.A., Bioceltix S.A., Pharmena S.A., onesano S.A., Poltreg S.A., Captor Therapeutics Spolka Akcyjna, BioMaxima S.A., Ryvu Therapeutics S.A. and Mabion S.A..
